PRRT2 Gene DYT10 NGS Genetic DNA Test
Comprehensive Genetic Testing for Movement Disorders
The PRRT2 Gene DYT10 NGS Genetic DNA Test represents a significant advancement in neurological genetic diagnostics, offering precise identification of mutations associated with paroxysmal kinesigenic dyskinesia (DYT10). This cutting-edge test utilizes Next Generation Sequencing (NGS) technology to analyze the PRRT2 gene, which plays a crucial role in neurotransmitter release and synaptic function within the nervous system.
What Does This Test Measure?
This comprehensive genetic analysis specifically targets the PRRT2 gene to detect pathogenic variants responsible for DYT10, a neurological condition characterized by sudden, brief episodes of involuntary movements. The test examines:
- Point mutations and small insertions/deletions in the PRRT2 gene
- Genetic variants affecting protein function and neurotransmitter regulation
- Inheritance patterns and familial risk assessment
- Specific mutations linked to episodic movement disorders
Who Should Consider This Test?
This genetic test is particularly recommended for individuals experiencing:
- Sudden, brief attacks of involuntary movements triggered by sudden motion
- Episodic dystonia or chorea lasting seconds to minutes
- Family history of similar movement disorders
- Unexplained neurological symptoms beginning in childhood or adolescence
- Previous inconclusive neurological evaluations
Key Benefits of PRRT2 Genetic Testing
Undergoing this advanced genetic analysis provides numerous advantages:
- Accurate Diagnosis: Confirms or rules out PRRT2-related disorders with high precision
- Personalized Treatment: Enables targeted therapeutic approaches based on genetic findings
- Family Planning: Provides crucial information for genetic counseling and reproductive decisions
- Prognostic Insights: Helps predict disease course and potential complications
- Research Contribution: Contributes to ongoing neurological genetics research
Understanding Your Test Results
Your genetic test results will be carefully interpreted by our expert genetic counselors and neurologists:
- Positive Result: Indicates the presence of a pathogenic PRRT2 mutation, confirming DYT10 diagnosis
- Negative Result: Suggests absence of known PRRT2 mutations, though other genetic causes may exist
- Variant of Uncertain Significance: Identifies genetic changes requiring further clinical correlation
- Carrier Status: Determines inheritance patterns and familial risk assessment
Test Pricing Information
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Nationwide Testing Availability
We proudly offer comprehensive genetic testing services across the United States, with convenient locations in major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art laboratories ensure consistent, high-quality results regardless of your location.
Take Control of Your Neurological Health
Don’t let unexplained movement disorders impact your quality of life. Our PRRT2 Gene DYT10 NGS Genetic DNA Test provides the clarity needed for proper diagnosis and management. With results available in 3-4 weeks and multiple sample collection options including blood, extracted DNA, or FTA card blood spots, getting tested has never been more convenient.
Ready to begin your genetic testing journey? Contact our genetic counseling team today at +1(267) 388-9828 to schedule your appointment or discuss your testing options. Our specialists are available to answer your questions and guide you through the testing process with compassion and expertise.
